Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Return on Sales (2018 - 2025)

TELA Bio has reported Return on Sales over the past 8 years, most recently at 1.45% for Q4 2025.

  • Quarterly results put Return on Sales at 1.45% for Q4 2025, down 21.0% from a year ago — trailing twelve months through Dec 2025 was 0.01% (changed 0.0% YoY), and the annual figure for FY2025 was 0.01%, down 1.0%.
  • Return on Sales for Q4 2025 was 1.45% at TELA Bio, up from 0.42% in the prior quarter.
  • Over the last five years, Return on Sales for TELA hit a ceiling of 1.66% in Q4 2024 and a floor of 1.39% in Q1 2021.
  • Median Return on Sales over the past 5 years was 0.8% (2023), compared with a mean of 0.61%.
  • Biggest five-year swings in Return on Sales: skyrocketed 246bps in 2024 and later decreased -27bps in 2025.
  • TELA Bio's Return on Sales stood at 1.02% in 2021, then grew by 11bps to 0.91% in 2022, then rose by 12bps to 0.8% in 2023, then skyrocketed by 307bps to 1.66% in 2024, then dropped by -13bps to 1.45% in 2025.
  • The last three reported values for Return on Sales were 1.45% (Q4 2025), 0.42% (Q3 2025), and 0.49% (Q2 2025) per Business Quant data.